barrett's%20esophagus
BARRETT'S ESOPHAGUS
Barrett's esophagus is defined as the endoscopic finding in the distal esophagus of proximal-appearing columnar-lined esophagus of at least 1-cm length that is confirmed by histology.
It is considered a premalignant metaplastic condition that usually involves the distal esophagus.
It is postulated that exposure of the esophageal epithelium to acid damages the lining resulting in chronic esophagitis and its healing involves metaplastic process.

Introduction

  • Barrett’s esophagus is considered a premalignant metaplastic condition that usually involves the distal esophagus
  • It is postulated that exposure of the esophageal epithelium to acid damages the lining resulting in chronic esophagitis and its healing involves metaplastic process
  • The incidence of progressing to adenocarcinoma is approximately 0.27-0.59% of Barrett’s esophagus patients per year
  • Barrett’s esophagus is diagnosed by endoscopy and histological examination

Definition

  • Defined as the endoscopic finding in the distal esophagus of proximal-appearing columnar-lined esophagus of at least 1-cm length that is confirmed by histology
    • Intestinal metaplasia is not required for diagnosis, though risk of progression to carcinoma is higher in its presence

Risk Factors

  • White or Hispanic race
  • Male
  • Advancing age (>50 years, reaching a plateau in the 60’s) - reported as a significant risk factor in various Asian studies
  • Hiatal hernia
  • Smoking
  • Central obesity (intra-abdominal body fat distribution)
  • Alcohol (as shown in an Asian study)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
27 Jan 2018
There is an over-representation of women in published reports of celecoxib drug-induced liver injury (DILI), according to a recent study. Latency has been shown to be short (<3 months) in most patients, but some of them may present with DILI after prolonged use of celecoxib.
22 Mar 2016
A recent study showed that routine use of alpha galactosidase (AG) has no benefit in irritable bowel syndrome (IBS) patients.
15 Nov 2017
Both hatha yoga and a low-FODMAP (Fermentable, Oligo-, Di-, Monosaccharides and Polyol) diet can alleviate gastrointestinal symptoms, as well as improve a range of other psychological and physiological health parameters, in patients with irritable bowel syndrome (IBS), a study has shown.
Rachel Soon, 14 Dec 2016

More well-designed studies are needed to confirm the benefits of various probiotics currently promoted for gut health, according to experts.